Sutro Biopharma
STRO
STRO
119 hedge funds and large institutions have $185M invested in Sutro Biopharma in 2024 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 28 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
39% less capital invested
Capital invested by funds: $302M → $185M (-$117M)
99% less call options, than puts
Call options by funds: $1K | Put options by funds: $91K
100% less funds holding in top 10
Funds holding in top 10: 3 → 0 (-3)
Holders
119
Holding in Top 10
–
Calls
$1K
Puts
$91K
Top Buyers
| 1 | +$12.3M | |
| 2 | +$5.66M | |
| 3 | +$3.75M | |
| 4 |
BlackRock
New York
|
+$3.54M |
| 5 |
EP
Eversept Partners
New York
|
+$1.9M |
Top Sellers
| 1 | -$3.09M | |
| 2 | -$2.49M | |
| 3 | -$1.43M | |
| 4 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$1.18M |
| 5 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$1.1M |